Meredith Cook - Apr 14, 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SR. VP, GENERAL COUNSEL & SEC.
Signature
/s/ Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Apr 14, 2025
Transactions value $
-$27,584
Form type
4
Date filed
4/14/2025, 04:17 PM
Previous filing
Mar 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$27.6K -400 -0.5% $68.96 80.1K Apr 14, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.